Comparison of Survival in Patients with Isolated Peritoneal Carcinomatosis from Colorectal Cancer Treated with Cytoreduction and Melphalan or Mitomycin-C as Hyperthermic Intraperitoneal Chemotherapy Agent

<div>Kaplan-Meier curves demonstrate overall survival of patients with PC from CRC treated with CRS/HIPEC. OS was calculated in 45 patients (patients with &gt;1 CRS/HIPEC were excluded).</div>

International Journal of Surgical Oncology

fig1

Figure 1

Figure 1: Comparison of Survival in Patients with Isolated Peritoneal Carcinomatosis from Colorectal Cancer Treated with Cytoreduction and Melphalan or Mitomycin-C as Hyperthermic Intraperitoneal Chemotherapy Agent 

Figure 1 | Comparison of Survival in Patients with Isolated Peritoneal Carcinomatosis from Colorectal Cancer Treated with Cytoreduction and Melphalan or Mitomycin-C as Hyperthermic Intraperitoneal Chemotherapy Agent 